ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Astrana Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$36.90+0.09 (+0.24%)
Close on Oct 19, 2026
- Market cap
- $1.84B
- P/E (TTM)
- 45.0
- Dividend yield
- –
Astrana Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Services-Management Consulting Services companies for comparison
Valuation
| Measure | Astrana Health | Industry median |
|---|---|---|
| Market Cap | $2.06B | $73.61M |
| Enterprise Value | $2.60B | $54.02M |
| PE Ratio | 45.00 | 25.83 |
| PS Ratio | 0.54 | 3.27 |
| PB Ratio | 2.48 | 2.99 |
| P/FCF Ratio | 21.79 | 19.55 |
| P/OCF Ratio | 19.07 | 15.58 |
Enterprise value
| Measure | Astrana Health | Industry median |
|---|---|---|
| EV / Sales | 0.68 | 2.80 |
| EV / EBITDA | 15.92 | 15.81 |
| EV / EBIT | 25.91 | 22.04 |
| EV / FCF | 27.58 | 21.35 |
Income (trailing twelve months)
| Measure | Astrana Health | Industry median |
|---|---|---|
| Revenue | $3.84B | $23.60M |
| Gross Profit | $402.00M | $19.54M |
| Operating Income | $100.46M | -$55.64K |
| Pretax Income | $60.10M | $45.62K |
| Net Income | $40.55M | -$80.05K |
| EBITDA | $163.48M | -$29.48K |
| EPS (Diluted) | $0.82 | $0.00 |
Margins
| Measure | Astrana Health | Industry median |
|---|---|---|
| Gross Margin | 10.5% | 40.4% |
| Operating Margin | 2.61% | 0.88% |
| Pretax Margin | 1.56% | 2.45% |
| Profit Margin | 1.05% | 0.51% |
| EBITDA Margin | 4.25% | 3.34% |
| FCF Margin | 2.46% | 5.05% |
Returns
| Measure | Astrana Health | Industry median |
|---|---|---|
| Return on Equity (ROE) | 5.08% | 1.35% |
| Return on Assets (ROA) | 2.18% | -3.16% |
| Return on Invested Capital (ROIC) | 5.95% | 2.85% |
| Return on Capital Employed (ROCE) | 6.55% | 2.03% |
Growth
| Measure | Astrana Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 58.9% | 4.74% |
| Net Income Growth (YoY) | 60.5% | 1.24% |
| EPS Growth (YoY) | 57.7% | 11.7% |
| FCF Growth (YoY) | -22.2% | -10.5% |
| Revenue Growth (3Y CAGR) | 40.6% | 4.21% |
| Revenue Growth (5Y CAGR) | 35.9% | 7.50% |
| EPS Growth (3Y CAGR) | -22.5% | 6.08% |
| EPS Growth (5Y CAGR) | -14.6% | 9.81% |
Balance sheet
| Measure | Astrana Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $400.79M | $5.43M |
| Total Debt | $936.50M | $90.03M |
| Net Cash (Debt) | -$535.71M | $17.62K |
| Net Cash Per Share | -$9.61 | $0.00 |
| Equity (Book Value) | $830.22M | $11.51M |
| Book Value Per Share | $14.90 | $0.64 |
| Tangible Book Value | -$300.08M | -$78.36K |
| Working Capital | $171.52M | $2.82M |
Financial position
| Measure | Astrana Health | Industry median |
|---|---|---|
| Current Ratio | 1.23 | 1.30 |
| Quick Ratio | 1.16 | 0.66 |
| Debt / Equity | 1.13 | 0.46 |
| Debt / EBITDA | 5.73 | 2.59 |
| Debt / FCF | 9.92 | 3.29 |
| Net Debt / EBITDA | 3.28 | 1.99 |
| Interest Coverage | 1.49 | -0.23 |
Cash flow (trailing twelve months)
| Measure | Astrana Health | Industry median |
|---|---|---|
| Operating Cash Flow | $107.87M | $8.04K |
| Capital Expenditures | -$13.49M | -$8.33M |
| Free Cash Flow | $94.38M | $11.03M |
| FCF Per Share | $1.69 | $0.76 |
Efficiency
| Measure | Astrana Health | Industry median |
|---|---|---|
| Asset Turnover | 2.06 | 0.81 |
| Revenue Per Employee | $1.28M | $215.67K |
| Profits Per Employee | $13.52K | -$799 |
| Employee Count | 3,000 | 115 |
Dividends and yields
| Measure | Astrana Health | Industry median |
|---|---|---|
| Earnings Yield | 1.97% | -0.97% |
| FCF Yield | 4.59% | 3.90% |
| Buyback Yield | 0.87% | 1.36% |
| Shareholder Yield | 0.87% | 1.65% |
| Payout Ratio | 4.57% | 43.9% |
| FCF Payout Ratio | 1.96% | 30.1% |
Shares
| Measure | Astrana Health | Industry median |
|---|---|---|
| Shares Outstanding | 55,737,200 | 29,217,800 |
| Shares Change (YoY) | 1.69% | 0.95% |
| Float | 38,614,200 | 26,226,050 |
| Shares Held by Insiders | 30.7% | 4.85% |
| Shares Held by Institutions | 57.7% | 83.3% |
Taxes
| Measure | Astrana Health | Industry median |
|---|---|---|
| Income Tax | $20.87M | $1.36M |
| Effective Tax Rate | 34.7% | 23.6% |
Scores
| Measure | Astrana Health | Industry median |
|---|---|---|
| Graham Number | $16.58 | $16.51 |
| Graham Upside | -55.1% | -50.2% |
| Altman Z-Score | 2.86 | 2.64 |
| Piotroski F-Score | 4 | 5 |
Calculated by StockData from Astrana Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.